Why this top dividend stock also has huge growth potential

This non-cyclical growth stock’s large and growing dividends have me very interested.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The annual dividend yield from shares of specialty mental health care provider Caretech (LSE: CTEC) fell from 3.5% to 2.4% after a recent rights issue but this should only make income and growth investors alike even more interested in the company.

For one, this is because the rights issue was to expand the already growing business, not a cash call from a desperate management team. Second, the business is benefiting from several significant tailwinds, including steady 5% annual market growth, a shortage of care facilities and increased outsourcing by the cash-strapped NHS.

The company’s interim report released on Thursday makes clear the long term potential for sales, profit and dividend growth remain incredibly bright. The company’s occupancy rates in mature facilities remained high at 93% while overall occupancy rates stayed strong at 86%.

While the interim report contained no financial information high occupancy rates suggests the company is continuing a string of good results. These include full year results for 2016 that saw 19.9% year-on-year revenue growth and a 19.6% increase in earnings per share that supported an 11.6% bump in dividend payments.

The £39m raised from the rights issue together with £11.5m in additional funds supplied by its banks, gives the company the financial firepower to go out and grow its estate through acquisitions. Management is still setting about finding prime targets but with a property portfolio worth £300m at year-end £50m will go a long way to significantly increasing revenue.

With tailwinds at its back, a well covered dividend, plenty of cash for acquisitions and a low valuation of 10.4 times forward earnings I view Caretech as one company fit for both growth and income investors.

You can’t escape this stock 

Longer lifespans are great for everyone except funeral homes such as the UK’s largest, Dignity (LSE: DTY). Shares in the company dropped over 15% in a single day last month after the company warned that lower numbers of deaths in 2017 and increased competition had forced it to lower medium term earnings growth targets.

This was especially bad news as Dignity has been priced for significant growth for some time as investors bet on the company gaining market share through steady organic growth and bolt-on acquisitions. The company’s share price has made up some lost ground since then and shares are now back to trading at a full 19.9 times forward earnings.

This is a lofty valuation but considering Dignity has a long history of successful acquisitions, raising margins and increasing cash flow it’s not a ridiculous one. But with a low dividend, high debt and a poor trading environment that led management to cut its own growth targets I’ll be steering clear of Dignity at this point.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »